Biosimilar FDA Approvals on Horizon As More States Enact Substitution Laws – The National Law Review

[ad_1] Biosimilar FDA Approvals on Horizon As More States Enact Substitution LawsThe National Law ReviewIn a sign of growing scientific acceptance and understanding of the biosimilar regulatory pathway, FDA’s Arthritis Advisory Committee (AAC) voted unanimously last month in favor of approving two new biosimilar products – GP2015, Sandoz’s biosimilar to ……